Shao Li

Shao Li (Chinese: 李梢) is a tenured professor at Tsinghua University.{{Cite web |last=Tsinghua University |title=Tsinghua University-Shao Li |url=https://www.au.tsinghua.edu.cn/info/1078/3172.htm |access-date=2024-01-08 |website=www.au.tsinghua.edu.cn}} His main research interest is in bioinformatics, network pharmacology and precision medicine on cancer prevention. Li is a member of the European Academy of Sciences and Arts,{{Cite web |last=Li |first=Shao |title=Member list of European Academy of Sciences and Arts |url=https://members.euro-acad.eu/#memberList |access-date=2024-06-27 |website=euro-acad.eu |language=en}} a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Biology, UK.{{Cite web |title=Shao Li |url=https://www.zgcforum.com.cn/en2024/guest/t2606/105226 |access-date=2025-01-14 |website=www.zgcforum.com.cn}} Li obtained his B.Sc from Beijing University of Chinese Medicine in 1995, M.S from Wannan College of Medicine in 1998 and M.D. from Beijing University of Chinese Medicine in 2001. He wrote the Network Pharmacology International Guideline in 2021{{Cite journal |last=Li |first=Shao |date= |title=Network Pharmacology Evaluation Method Guidance |url=https://www.wjtcm.net/article.asp?issn=2311-8571;year=2021;volume=7;issue=1;spage=146;epage=154;aulast=Li;type=0 |journal=World Journal of Traditional Chinese Medicine |language=en |volume=7 |issue=1 |pages=146–154 |doi=10.4103/wjtcm.wjtcm_11_21 |issn=2311-8571 |s2cid=232328891 |doi-access=free|url-access=subscription }} and was the editor of the network pharmacology monograph (Springer Press) in 2021.{{Cite book |date=2021 |editor-last=Li |editor-first=Shao |title=Network Pharmacology |url=https://link.springer.com/book/10.1007/978-981-16-0753-0 |language=en |doi=10.1007/978-981-16-0753-0|isbn=978-981-16-0752-3 |s2cid=78332992 }} He proposed the theory and technologies of "network target"{{Cite journal |last=Li |first=Shao |date=2015 |title=Mapping ancient remedies: Applying a network approach to traditional Chinese medicine |url=https://www.cheric.org/research/tech/periodicals/view.php?seq=1438886 |journal=Science |language= |volume=350 |issue=6262 |pages=S72–S74}} and natural medicine network pharmacology (ESI highly cited paper and ESI hot spot paper).{{Cite journal |last1=Li |first1=Shao |last2=Zhang |first2=Bo |date=2013-03-01 |title=Traditional Chinese medicine network pharmacology: theory, methodology and application |url=https://www.sciencedirect.com/science/article/pii/S1875536413600370 |journal=Chinese Journal of Natural Medicines |language=en |volume=11 |issue=2 |pages=110–120 |doi=10.1016/S1875-5364(13)60037-0 |issn=1875-5364 |pmid=23787177 |s2cid=1252771|url-access=subscription }} Li established the “exceedingly-early” paradigm of cancer diagnosis and interception, with significantly improving the clinical prevention efficiency for gastric cancer.{{Cite web |last=Association |first=China Anti-Cancer |title=Deciphering inflammation-induced tumorigenesis: Unveiling gastric cancer's trail with network and AI |url=https://medicalxpress.com/news/2024-08-deciphering-inflammation-tumorigenesis-unveiling-gastric.html |access-date=2025-01-14 |website=medicalxpress.com |language=en}}{{Cite journal |last1=Zhang |first1=Peng |last2=Zhang |first2=Qian |last3=Li |first3=Shao |date=2024-11-01 |title=Advancing Cancer Prevention through an AI-Based Integration of Traditional and Western Medicine |url=https://aacrjournals.org/cancerdiscovery/article-abstract/14/11/2033/749202/Advancing-Cancer-Prevention-through-an-AI-Based?redirectedFrom=fulltext |journal=Cancer Discovery |volume=14 |issue=11 |pages=2033–2036 |doi=10.1158/2159-8290.CD-24-0832 |pmid=39485250 |issn=2159-8274|url-access=subscription }}

Academic memberships

Li is currently serving as the director of the first Tsinghua University Interdisciplinary Institute of Traditional Chinese Medicine,{{Cite web |last=Li |first=Shao |title=Tsinghua University Institute of TCM-X,Beijing |url=https://tcmx.tsinghua.edu.cn/en/info/1541/2749.htm |access-date=2023-11-08 |website=tcmx.tsinghua.edu.cn |language=EN}} and the Chairman of the Specialty Committee of Network Pharmacology of the World Federation of Chinese Medicine Society and Specialty Committee of Biomedical Big Data of the Chinese Society of Biotechnology. He also serves as Editorial Board Members including Cancer Biology & Medicine,{{Cite web |title=Editorial Board {{!}} Cancer Biology & Medicine |url=https://www.cancerbiomed.org/content/editorial-board |access-date=2023-11-07 |website=www.cancerbiomed.org}} Pharmacological Research,{{Cite web |title=Editorial board - Pharmacological Research {{!}} ScienceDirect.com by Elsevier |url=https://www.sciencedirect.com/journal/pharmacological-research/about/editorial-board |access-date=2023-11-07 |website=www.sciencedirect.com}} Journal of Ethnopharmacology. He has delivered keynote speeches in the NIH/NCI and other international conferences.{{Cite web |title=State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research—NCI Strategic Workshop Highlights of Discussion Report |url=https://academic.oup.com/jncimono/article/2017/52/lgx003/4617818?login=false |access-date=2023-11-07 |journal=JNCI Monographs| date=2017 | doi=10.1093/jncimonographs/lgx003 | last1=Xi | first1=Dan | last2=Bao | first2=Ting | last3=Chen | first3=Qi | last4=Chen | first4=Sushing | last5=Cheng | first5=Yung-chi | last6=Cullen | first6=Joseph | last7=Frank | first7=David A. | last8=Friedberg | first8=Jonathan W. | last9=Kronish | first9=Ian | last10=Lee | first10=Jeffrey E. | last11=Levine | first11=Mark | last12=Li | first12=Pingping | last13=Li | first13=Shao | last14=Lu | first14=Weidong | last15=Mao | first15=Jun J. | last16=o'Keefe | first16=Stephen | last17=Rubinstein | first17=Larry | last18=Shah | first18=Manish A. | last19=Standish | first19=Leanna | last20=Paller | first20=Channing J. | last21=Chu | first21=Edward | issue=52 | pages=lgx003 | pmid=29140484 | pmc=6061228 }}

He has been recognized as one of the top 2% Scientists Worldwide in 2019/2020/2021/2022/2023/2024 (by Stanford University).{{Cite journal |last1=Baas |first1=Jeroen |last2=Boyack |first2=Kevin |last3=Ioannidis |first3=John P. A. |date=2021-10-19 |title=August 2021 data-update for "Updated science-wide author databases of standardized citation indicators" |url=https://elsevier.digitalcommonsdata.com/datasets/btchxktzyw/3 |journal=Elsevier Data Repository |language=en |publisher=Elsevier BV |volume=3 |doi=10.17632/btchxktzyw.3}}{{Cite journal |last=Ioannidis |first=John P. A. |date=2024-09-16 |title=August 2024 data-update for "Updated science-wide author databases of standardized citation indicators" |url=https://elsevier.digitalcommonsdata.com/datasets/btchxktzyw/7 |journal=Elsevier Data Repository |language=en |volume=7 |doi=10.17632/btchxktzyw.7}} He won the top award of both Gold Medal with congratulations of the Jury and Gold Medal in the 49th Geneva International Exhibition of Inventions (2024). He has also received 2024 China Pharmaceutical Development Award,{{Cite web |title=Tsinghua Professor Li Shao wins 2024 China Pharmaceutical Development Award-Tsinghua University |url=https://www.tsinghua.edu.cn/en/info/1245/13659.htm |access-date=2025-01-14 |website=www.tsinghua.edu.cn}} the 1st Class of International Award for Outstanding Contribution to Chinese Medicine in 2020,{{Cite web |title=International Award for Outstanding Contribution to Chinese Medicine |url=https://www.au.tsinghua.edu.cn/info/1133/3413.htm |access-date=2023-11-07 |website=www.au.tsinghua.edu.cn}} and the Li Shizhen Pharmaceutical Innovation Award in 2019. He was also awarded Grand Challenges 2015—Young Scientists (Bill & Melinda Gates Foundation, 2015), the National Outstanding Young Scientist (China, 2012), the first network pharmacology patent (USA, 2012),{{Cite patent|number=US8112230B2|title=Method of network-based identification of multicomponent synergy and compositions for use as effective component of anti-angiogenesis medicines|gdate=2012-02-07|invent1=Zhang|invent2=Li|invent3=Zhang|inventor1-first=Ningbo|inventor2-first=Shao|inventor3-first=Bo|url=https://patents.google.com/patent/US8112230B2/en?oq=US8112230B2}} and National Science and Technology Progress Award (China, 2004)

External links

[http://tcmx.tsinghua.edu.cn/en/info/1541/2749.htm Shao Li-Tsinghua University Institute of TCM-X,Beijing]

References

Category:Tsinghua University people

Category:Fellows of the Royal Society of Chemistry

Category:Fellows of the Royal Society of Biology

Category:Year of birth missing (living people)

Category:Living people